https://www.selleckchem.com/pr....oducts/chloroquine.h
Of 20 evaluable Ph-positive ALL patients, major molecular response was achieved in 19 patients (95%); complete molecular response in 14(70%). Grade 3/4 peripheral neuropathy was observed in 5(16%) with all grade peripheral neuropathy in 21(68%). With a median follow-up of 59 months, 21(68%) patients are alive. The 5-year CR duration and survival rates were 73% and 61%, respectively; median CR duration and survival was not reached and not reached, respectively. Ten(32%) patients died 1, sepsis on C1D10; 4, unknown; 1, post-transplant